Fundz

Evident Vascular has closed a Series B financing round to enhance its AI-powered intravascular ultrasound platform. Founded by Vensana Capital, the round included new investors Shangbay Capital and others.

PRIVATEMar 25, 2025

Round Type

Series B

San JoseInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMedical

Investors

Shangbay CapitalVensana Capital

Description

Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The company did not disclose the amount raised in this round. The funds will be used to accelerate development and support FDA 510(k) clearance ahead of a U.S. launch

Who to call at Evident Vascular, and when

A new round usually means Evident Vascular is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Evident Vascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evident Vascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evident Vascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evident Vascular

Location

San Jose, California, United States

About

Evident Vascular is a medical technology company focused on developing an AI-powered intravascular ultrasound (IVUS) platform. Their technology aims to enhance vascular imaging and improve patient outcomes in clinical practice. Founded to innovate intravascular imaging, they are committed to expanding the utility and accessibility of IVUS. The company recently closed a Series B financing round to support the FDA 510(k) clearance of their technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evident Vascular raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Evident Vascular's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Evident Vascular raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.